GlassScriptPhysician profile
Harry L Kanter
NPI 1215902697
$7,634.86
in general payments reported to CMS, 2019-2025
38 companies · $342 in 2025
The $342 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,645 · 2020: $969 · 2021: $1,131 · 2022: $1,293 · 2023: $404 · 2024: $1,851 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,306 · Travel and Lodging: $1,291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,305.80 |
| Travel and Lodging | $1,291.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $1,833.75 | 2019-2025 | Acticor 7 Vr-T Dx, Amvia Edge, Biomonitor |
| Medtronic, INC. | $1,772.94 | 2021-2024 | Micra |
| Novartis Pharmaceuticals Corporation | $741.02 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $382.58 | 2019-2023 | Xarelto |
| Abbott Laboratories | $374.76 | 2019-2025 | Aveir, Jot Dx, Ensite |
| Amgen INC. | $265.92 | 2019-2022 | |
| Boston Scientific Corporation | $210.50 | 2019-2025 | Accolade Sr, Farapulse |
| Astrazeneca Pharmaceuticals LP | $201.61 | 2019-2025 | Wainua |
| Pfizer INC. | $188.44 | 2019-2022 | |
| Cvrx, INC. | $161.73 | 2022-2023 | Barostim Neo System |
| Amarin Pharma, INC. | $129.31 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $115.08 | 2019-2025 | Lifevest |
| Regeneron Healthcare Solutions, INC. | $107.97 | 2019 | |
| Philips North America LLC | $107.46 | 2019-2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Boehringer Ingelheim Pharmaceuticals, INC. | $94.25 | 2019-2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $88.06 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $83.21 | 2019-2022 | |
| Braemar Manufacturing, LLC | $79.98 | 2019 | |
| Sanofi-Aventis U.S. LLC | $67.79 | 2019-2021 | |
| Preventice Services, LLC | $66.94 | 2021 | |
| Merck Sharp & Dohme LLC | $59.44 | 2021-2022 | |
| Medtronic Vascular, INC. | $48.97 | 2020 | |
| Esperion Therapeutics, INC. | $48.09 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $46.95 | 2022 | |
| Vifor Pharma, INC. | $46.81 | 2019 | |
| Lundbeck LLC | $44.73 | 2019 | |
| Irhythm Technologies, INC. | $33.07 | 2020-2022 | |
| Portola Pharmaceuticals, LLC | $32.58 | 2019-2020 | |
| Novo Nordisk INC | $29.52 | 2019 | |
| Cardiovascular Systems INC. | $27.21 | 2023 | Diamondback Coronary |
| Baxter Healthcare | $27.02 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Lilly USA, LLC | $26.37 | 2019 | |
| Medicomp INC | $20.97 | 2022 | |
| Bardy Diagnostics, INC. | $20.00 | 2022 | |
| Amryt Pharma Holdings LTD | $17.04 | 2022 | |
| Corindus INC. | $12.95 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.09 | 2019 | |
| G Medical Diagnostic Services, INC. | $8.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harry Kanter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.